Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ1S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $148,625
Award facts
- Contract value 100% obligated
- $148,625.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $148,625.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Wegovy 2.4 mg/0.75 mL pen injections, with a completion date of January 20, 2026. This non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems.
AmerisourceBergen's role as a major pharmaceutical vendor to the federal government is well-established through its extensive portfolio of delivery orders covering diabetes medications, neurological treatments, and specialized medical supplies. The parent company, Cencora, Inc., competes on a full and open basis for federal contracts and maintains significant IDCs with multiple agencies including the Department of Veterans Affairs and the Department of Justice Federal Bureau of Investigation. This particular delivery order for Wegovy, a diabetes and weight management medication, aligns with the company's demonstrated capability to efficiently fulfill government contracts for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FJJ1S?
SPE2DR26FJJ1S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FJJ1S worth?
The government has obligated $148,625 on SPE2DR26FJJ1S.
Is contract SPE2DR26FJJ1S an order under another contract?
Yes. SPE2DR26FJJ1S is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ1S competed?
The extent of competition for SPE2DR26FJJ1S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award